Acalabrutinib and Obinutuzumab for the Treatment of Chronic Lymphocytic Leukemia
Clinical trial NCT04505254 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04505254
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-25
- Primary completion
- 2027-06-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.